Literature DB >> 19207043

Development of decellularized human umbilical arteries as small-diameter vascular grafts.

Liqiong Gui1, Akihito Muto, Stephen A Chan, Christopher K Breuer, Laura E Niklason.   

Abstract

OBJECTIVE: Developing a tissue-engineered small-diameter (<6mm) vascular graft for reconstructive surgery has remained a challenge for the past several decades. This study was conducted to develop a decellularized umbilical artery and to evaluate its composition, endothelial cell compatibility, mechanical properties, and in vivo stability for potential use as a small-diameter vascular graft. METHODS AND
RESULTS: Human umbilical arteries were isolated and decellularized by incubation in CHAPS and sodium dodecyl sulfate buffers followed by incubation in endothelial growth media-2. Decellularized umbilical arteries were completely devoid of cellular and nuclear material while retaining the integrity of extracellular collagenous matrix. The mechanical strength of the decellularized umbilical artery as assessed by its burst pressure in vitro showed no significant change from its native form. Decellularized umbilical arteries supported endothelial adherence as indicated by the re-endotheliazation with a monolayer of human umbilical vein endothelial cells. Furthermore, decellularized vessels that were implanted into nude rats as abdominal aorta interposition grafts remained mechanically intact and patent for up to 8 weeks.
CONCLUSION: Decellularized human umbilical arteries preserved the extracellular matrix, supported endothelialization, and retained function in vivo for up to 8 weeks. These properties suggest the potential use of decellularized umbilical arteries as small-diameter vascular grafts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19207043      PMCID: PMC2735599          DOI: 10.1089/ten.tea.2008.0526

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  50 in total

1.  Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix.

Authors:  O E Teebken; A Bader; G Steinhoff; A Haverich
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-04       Impact factor: 7.069

2.  ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

Authors:  Kim A Eagle; Robert A Guyton; Ravin Davidoff; Fred H Edwards; Gordon A Ewy; Timothy J Gardner; James C Hart; Howard C Herrmann; L David Hillis; Adolph M Hutter; Bruce Whitney Lytle; Robert A Marlow; William C Nugent; Thomas A Orszulak
Journal:  Circulation       Date:  2004-10-05       Impact factor: 29.690

3.  Recellularization of decellularized allograft scaffolds in ovine great vessel reconstructions.

Authors:  Ara Ketchedjian; Alyce Linthurst Jones; Paula Krueger; Elliot Robinson; Katrina Crouch; Lloyd Wolfinbarger; Richard Hopkins
Journal:  Ann Thorac Surg       Date:  2005-03       Impact factor: 4.330

4.  Tissue engineering of recellularized small-diameter vascular grafts.

Authors:  Gregory H Borschel; Yen-Chih Huang; Sarah Calve; Ellen M Arruda; Jennifer B Lynch; Douglas E Dow; William M Kuzon; Robert G Dennis; David L Brown
Journal:  Tissue Eng       Date:  2005 May-Jun

5.  A blood vessel model constructed from collagen and cultured vascular cells.

Authors:  C B Weinberg; E Bell
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

6.  In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study.

Authors:  N L'Heureux; L Germain; R Labbé; F A Auger
Journal:  J Vasc Surg       Date:  1993-03       Impact factor: 4.268

7.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.

Authors:  S Kaushal; G E Amiel; K J Guleserian; O M Shapira; T Perry; F W Sutherland; E Rabkin; A M Moran; F J Schoen; A Atala; S Soker; J Bischoff; J E Mayer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

Review 8.  Apoptosis. Basic concepts and implications in coronary artery disease.

Authors:  P J Best; D Hasdai; G Sangiorgi; R S Schwartz; D R Holmes; R D Simari; A Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-01       Impact factor: 8.311

9.  Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty.

Authors:  G E Austin; N B Ratliff; J Hollman; S Tabei; D F Phillips
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

10.  Autogenous veins and velour dacron in femoropopliteal arterial bypass.

Authors:  M Stephen; J Loewenthal; J M Little; J May; A G Sheil
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

View more
  69 in total

1.  A novel ovine ex vivo arteriovenous shunt model to test vascular implantability.

Authors:  Haofan Peng; Evan M Schlaich; Sindhu Row; Stelios T Andreadis; Daniel D Swartz
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

2.  Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media.

Authors:  Hao-Fan Peng; Jin Yu Liu; Stelios T Andreadis; Daniel D Swartz
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

3.  In vivo performance of a phospholipid-coated bioerodable elastomeric graft for small-diameter vascular applications.

Authors:  Lorenzo Soletti; Alejandro Nieponice; Yi Hong; Sang-Ho Ye; John J Stankus; William R Wagner; David A Vorp
Journal:  J Biomed Mater Res A       Date:  2010-12-09       Impact factor: 4.396

Review 4.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

5.  Novel utilization of serum in tissue decellularization.

Authors:  Liqiong Gui; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part C Methods       Date:  2010-04       Impact factor: 3.056

Review 6.  Stem cell sources for vascular tissue engineering and regeneration.

Authors:  Vivek K Bajpai; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2012-07-03       Impact factor: 6.389

7.  Construction of tissue-engineered small-diameter vascular grafts in fibrin scaffolds in 30 days.

Authors:  Liqiong Gui; Michael J Boyle; Yishai M Kamin; Angela H Huang; Barry C Starcher; Cheryl A Miller; Michael J Vishnevetsky; Laura E Niklason
Journal:  Tissue Eng Part A       Date:  2014-02-06       Impact factor: 3.845

8.  Removal of an abluminal lining improves decellularization of human umbilical arteries.

Authors:  Ho-Yi Tuan-Mu; Yi-Hao Chang; Jin-Jia Hu
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

9.  Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium.

Authors:  Mehmet H Kural; Juan Wang; Liqiong Gui; Yifan Yuan; Guangxin Li; Katherine L Leiby; Elias Quijano; George Tellides; W Mark Saltzman; Laura E Niklason
Journal:  Biomaterials       Date:  2019-05-07       Impact factor: 12.479

10.  Design and Use of a Novel Bioreactor for Regeneration of Biaxially Stretched Tissue-Engineered Vessels.

Authors:  Angela Hai Huang; Yong-Ung Lee; Elizabeth A Calle; Michael Boyle; Barry C Starcher; Jay D Humphrey; Laura E Niklason
Journal:  Tissue Eng Part C Methods       Date:  2015-03-20       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.